KEYFORM-008: Coformulated favezelimab and pembrolizumab (MK4280A) versus chemotherapy in relapsed/refractory classical Hodgkin lymphoma.


Lavie D., Timmerman J., Sanz R. G., Kim W. S., Kim T. M., Avigdor A., ...More

JOURNAL OF CLINICAL ONCOLOGY, vol.41, no.16, 2023 (SCI-Expanded, Scopus)

  • Publication Type: Article / Abstract
  • Volume: 41 Issue: 16
  • Publication Date: 2023
  • Journal Name: JOURNAL OF CLINICAL ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, Gender Studies Database, International Pharmaceutical Abstracts, Veterinary Science Database
  • Ankara University Affiliated: Yes